Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes.
Guardiola M, Rehues P, Amigó N, Arrieta F, Botana M, Gimeno-Orna JA, Girona J, Martínez-Montoro JI, Ortega E, Pérez-Pérez A, Sánchez-Margalet V, Pedro-Botet J, Ribalta J; Cardiovascular Disease Group of the Spanish Society of Diabetes.
Guardiola M, et al.
Eur J Clin Invest. 2024 Aug;54(8):e14214. doi: 10.1111/eci.14214. Epub 2024 Apr 13.
Eur J Clin Invest. 2024.
PMID: 38613414
Review.